Header Logo

Connection

MICHELE YORK to Female

Back to Details
This is a "connection" page, showing publications MICHELE YORK has written about Female.
MICHELE YORK
Connection Strength
0.373
Female
  1. Benefit of phonemic cueing on confrontation naming in Alzheimer's disease. Clin Neuropsychol. 2020 02; 34(2):368-383.
    View in: PubMed
    Score: 0.023
  2. Performance Validity in Deep Brain Stimulation Candidates. Arch Clin Neuropsychol. 2018 Jun 01; 33(4):508-514.
    View in: PubMed
    Score: 0.022
  3. Comparative Patient Satisfaction and Feasibility of a Pilot Parkinson's Disease Enrichment Program. J Geriatr Psychiatry Neurol. 2017 Sep; 30(5):253-260.
    View in: PubMed
    Score: 0.021
  4. Alternating verbal fluency performance following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease. Eur J Neurol. 2012 Dec; 19(12):1525-31.
    View in: PubMed
    Score: 0.014
  5. The Rey 15-item memory test and Spanish-speaking older adults. Clin Neuropsychol. 2011 Oct; 25(7):1253-65.
    View in: PubMed
    Score: 0.014
  6. Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease. Eur J Neurol. 2012 Jan; 19(1):121-7.
    View in: PubMed
    Score: 0.014
  7. Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation. Parkinsonism Relat Disord. 2011 Jun; 17(5):321-7.
    View in: PubMed
    Score: 0.013
  8. Frontal and temporal lobe involvement on verbal fluency measures in amyotrophic lateral sclerosis. J Clin Exp Neuropsychol. 2010 Nov; 32(9):913-22.
    View in: PubMed
    Score: 0.013
  9. Relationship between neuropsychological outcome and DBS surgical trajectory and electrode location. J Neurol Sci. 2009 Dec 15; 287(1-2):159-71.
    View in: PubMed
    Score: 0.012
  10. Five-year follow-up of unilateral posteroventral pallidotomy in Parkinson's disease. Surg Neurol. 2009 May; 71(5):551-8.
    View in: PubMed
    Score: 0.011
  11. Depressed mood and memory impairment before and after unilateral posteroventral pallidotomy in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2008; 20(3):357-63.
    View in: PubMed
    Score: 0.011
  12. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2008 Jul; 79(7):789-95.
    View in: PubMed
    Score: 0.011
  13. Short and long-term motor and cognitive outcome of staged bilateral pallidotomy: a retrospective analysis. Acta Neurochir (Wien). 2007; 149(9):857-66; discussion 866.
    View in: PubMed
    Score: 0.010
  14. Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior Disorder. Ann Neurol. 2025 Sep; 98(3):482-491.
    View in: PubMed
    Score: 0.009
  15. Baseline cognition and demographic, lifestyle, and cardiovascular risk factors in US POINTER. Alzheimers Dement. 2025 Jul; 21(7):e70216.
    View in: PubMed
    Score: 0.009
  16. Associations Between Deficit Accumulation Frailty and Baseline Markers of Lifestyle in the U.S. POINTER Trial. J Gerontol A Biol Sci Med Sci. 2025 Jan 16; 80(2).
    View in: PubMed
    Score: 0.009
  17. Use of Robust Norming to Create a Sensitive Cognitive Summary Score in De Novo Parkinson's Disease: An Illustrative Example. Mov Disord. 2025 Mar; 40(3):468-477.
    View in: PubMed
    Score: 0.009
  18. Long-Term Dementia Risk in Parkinson Disease. Neurology. 2024 09 10; 103(5):e209699.
    View in: PubMed
    Score: 0.008
  19. Seizure control and cognitive outcome after temporal lobectomy: a comparison of classic Ammon's horn sclerosis, atypical mesial temporal sclerosis, and tumoral pathologies. Epilepsia. 2003 Mar; 44(3):387-98.
    View in: PubMed
    Score: 0.008
  20. Clustering and switching in phonemic fluency following pallidotomy for the treatment of Parkinson's disease. J Clin Exp Neuropsychol. 2003 Feb; 25(1):110-21.
    View in: PubMed
    Score: 0.008
  21. Tele-Medicine Based and Self-Administered Interactive Exercise Program (Tele-Exergame) to Improve Cognition in Older Adults with Mild Cognitive Impairment or Dementia: A Feasibility, Acceptability, and Proof-of-Concept Study. Int J Environ Res Public Health. 2022 Dec 06; 19(23).
    View in: PubMed
    Score: 0.008
  22. Care4AD: A Technology-Driven Platform for Care Coordination and Management: Acceptability Study in Dementia. Gerontology. 2023; 69(2):227-238.
    View in: PubMed
    Score: 0.007
  23. Verbal working memory storage and processing deficits in HIV-1 asymptomatic and symptomatic individuals. Psychol Med. 2001 Oct; 31(7):1279-91.
    View in: PubMed
    Score: 0.007
  24. Decrease in Mobility during the COVID-19 Pandemic and Its Association with Increase in Depression among Older Adults: A Longitudinal Remote Mobility Monitoring Using a Wearable Sensor. Sensors (Basel). 2021 Apr 29; 21(9).
    View in: PubMed
    Score: 0.007
  25. Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease. Ann Clin Transl Neurol. 2020 04; 7(4):449-461.
    View in: PubMed
    Score: 0.006
  26. Acute readmission following deep brain stimulation surgery for Parkinson's disease: A nationwide analysis. Parkinsonism Relat Disord. 2020 01; 70:96-102.
    View in: PubMed
    Score: 0.006
  27. Pseudobulbar Affect Correlates With Mood Symptoms in Parkinsonian Disorders but Not Amyotrophic Lateral Sclerosis. J Neuropsychiatry Clin Neurosci. 2018; 30(3):214-219.
    View in: PubMed
    Score: 0.005
  28. Leg stereotypy syndrome: phenomenology and prevalence. J Neurol Neurosurg Psychiatry. 2018 07; 89(7):692-695.
    View in: PubMed
    Score: 0.005
  29. Physical Activity Recommendations for the Aging Brain: A Clinician-Patient Guide. Arch Phys Med Rehabil. 2016 06; 97(6):1045-7.
    View in: PubMed
    Score: 0.005
  30. Skin irritation testing in man for hazard assessment--evaluation of four patch systems. Hum Exp Toxicol. 1995 Sep; 14(9):729-34.
    View in: PubMed
    Score: 0.005
  31. Neurocognitive deficits increase risk of poor retention in care among older adults with newly diagnosed HIV infection. AIDS. 2015 Aug 24; 29(13):1711-4.
    View in: PubMed
    Score: 0.005
  32. A Pilot Study of a Cognitive-Behavioral Treatment for Anxiety and Depression in Patients With Parkinson Disease. J Geriatr Psychiatry Neurol. 2015 Sep; 28(3):210-7.
    View in: PubMed
    Score: 0.004
  33. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. J Neurol Neurosurg Psychiatry. 2015 Jun; 86(6):622-9.
    View in: PubMed
    Score: 0.004
  34. Impulsive and compulsive behaviors in Parkinson Study Group (PSG) centers performing deep brain stimulation surgery. J Parkinsons Dis. 2014; 4(4):591-8.
    View in: PubMed
    Score: 0.004
  35. TM4SF20 ancestral deletion and susceptibility to a pediatric disorder of early language delay and cerebral white matter hyperintensities. Am J Hum Genet. 2013 Aug 08; 93(2):197-210.
    View in: PubMed
    Score: 0.004
  36. Influence of socio-demographic characteristics on DRS-2 performance in Spanish-speaking older adults. Arch Clin Neuropsychol. 2012 Aug; 27(5):545-56.
    View in: PubMed
    Score: 0.004
  37. Assessment of appropriate medication administration for hospitalized patients with Parkinson's disease. Parkinsonism Relat Disord. 2012 May; 18(4):377-81.
    View in: PubMed
    Score: 0.004
  38. Cognitive behavioral therapy for depression and anxiety in Parkinson's disease: a clinical review. J Parkinsons Dis. 2012; 2(2):135-51.
    View in: PubMed
    Score: 0.004
  39. The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism. Parkinsonism Relat Disord. 2011 Sep; 17(8):625-8.
    View in: PubMed
    Score: 0.003
  40. Does apolipoprotein E genotype modify the clinical expression of ALS? Eur J Neurol. 2011 Apr; 18(4):618-24.
    View in: PubMed
    Score: 0.003
  41. A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS. Amyotroph Lateral Scler. 2010 Dec; 11(6):542-8.
    View in: PubMed
    Score: 0.003
  42. Improvement of neurological symptoms and memory and emotional status in a case of seronegative Sneddon syndrome with cyclophosphamide. Clin Neurol Neurosurg. 2010 Jul; 112(6):544-7.
    View in: PubMed
    Score: 0.003
  43. Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS). Amyotroph Lateral Scler. 2010 May 03; 11(3):303-11.
    View in: PubMed
    Score: 0.003
  44. Differences between clinical subspecialties in the outpatient evaluation and treatment of dementia in an academic medical center. Dement Geriatr Cogn Disord. 2010; 29(1):28-36.
    View in: PubMed
    Score: 0.003
  45. ALS disease onset may occur later in patients with pre-morbid diabetes mellitus. Eur J Neurol. 2010 May; 17(5):733-9.
    View in: PubMed
    Score: 0.003
  46. Ethnic disparities in the treatment of dementia in veterans. Dement Geriatr Cogn Disord. 2009; 28(2):145-52.
    View in: PubMed
    Score: 0.003
  47. Predictors of individual visual memory decline after unilateral anterior temporal lobe resection. Neurology. 2009 May 26; 72(21):1837-42.
    View in: PubMed
    Score: 0.003
  48. Memory, emotional and vocational impairments before and after anterior temporal lobectomy for complex partial seizures. Epilepsia. 2006 Nov; 47(11):1922-30.
    View in: PubMed
    Score: 0.002
  49. Neuropsychological outcome after unilateral pallidotomy for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry. 2000 Sep; 69(3):326-36.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.